Targeted Therapies for Patients with HCC

Thomas A. Abrams, MD of Dana Farber Cancer Institute discusses how targeted therapies seem to work better for patients with HCC at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in San Francisc... Author: obr Added: 01/25/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts